In Reply to the Discovery Trial Report Evaluating the Potential Benefit of Hydroxychloroquine, Lopinavir and Ritonavir with and Without Interferon Β-1a in Hospitalized Covid-19 Patients
Abstract
Abstract not available in the source database.
This work is licensed under a Creative Commons Attribution 4.0 International License
